NEW YORK (Reuters Health) – A South African study shows that HIV-infected patients do better when they begin treatment above rather than below 200 cells/µL. The results, reported…
NEW YORK (Reuters Health) – According to a new report, primary care patients who may have a drug use disorder can be reliably identified with a single-question screening…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement…
NEW YORK (Reuters Health) – In managing hospitalized patients who develop candidemia, the standard practice of promptly removing a central venous catheter does not improve outcomes, according a…
NEW YORK (Reuters Health) – Urinary tract infections occur quite often after patients are given detrusor injections of botulinum toxin A (BoNT-A) to reduce bladder overactivity, so prophylactic…
NEW YORK (Reuters Health) – First-line therapy with zidovudine and interferon-alpha improves overall survival in patients with adult T-cell leukemia/lymphoma (ATL), according to the results of a retrospective…
NEW YORK (Reuters Health) – Patients with chronic heart failure have a higher mortality risk or are more likely to undergo a heart transplant if they have low…
NEW YORK (Reuters Health) – When children with overactive bladder have a poor response to medical therapy, a course of transcutaneous electrical nerve stimulation (TENS) applied to the…
NEW YORK (Reuters Health) –There’s no reliable evidence to support or refute the use of glucocorticoids for treating anaphylaxis, despite recommendations found in several guidelines, according to the…